Akebia Therapeutics SG&A Expense (Quarterly) Insights

Akebia Therapeutics Inc (AKBA)

1.155 +0.02 (+1.32%) USD | NASDAQ | May 17, 16:00

1.155 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	25.44M
December 31, 2023	25.44M
September 30, 2023	22.71M
June 30, 2023	27.04M
March 31, 2023	25.05M
December 31, 2022	29.91M
September 30, 2022	31.89M
June 30, 2022	32.24M
March 31, 2022	44.33M
December 31, 2021	44.80M
September 30, 2021	46.36M
June 30, 2021	41.65M
March 31, 2021	41.33M
December 31, 2020	40.46M
September 30, 2020	40.17M
June 30, 2020	35.48M
March 31, 2020	37.98M
December 31, 2019	44.92M
September 30, 2019	34.18M
June 30, 2019	36.07M
March 31, 2019	34.29M
December 31, 2018	55.12M
September 30, 2018	10.38M

Date	Value
June 30, 2018	12.54M
March 31, 2018	9.024M
December 31, 2017	7.567M
September 30, 2017	6.748M
June 30, 2017	6.905M
March 31, 2017	5.788M
December 31, 2016	6.144M
September 30, 2016	4.944M
June 30, 2016	5.311M
March 31, 2016	5.811M
December 31, 2015	5.806M
September 30, 2015	4.074M
June 30, 2015	4.384M
March 31, 2015	4.232M
December 31, 2014	5.674M
September 30, 2014	2.936M
June 30, 2014	2.315M
March 31, 2014	3.751M
December 31, 2013	4.89M
September 30, 2013	0.794M
June 30, 2013	0.6678M
March 31, 2013	0.6789M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

22.71M

Minimum

Sep 2023

46.36M

Maximum

Sep 2021

35.37M

Average

35.78M

Median

SG&A Expense (Quarterly) Benchmarks